Expected earnings - Nuvectis Pharma Inc.
Source: US Earnings Reports
Nuvectis Pharma Inc. (NVCT) is expected to report $-0.25 for Q2 2025
Nuvectis Pharma Inc.
NASDAQ: NVCT
NVCT Trading
-6.16% G/L:
$9.21 Last:
23,708 Volume:
$9.54 Open:
NVCT Latest News
February 11, 2026 07:30:00 am
Nuvectis Pharma, Inc. Reports 2025 Financial Results and Business Highlights
NVCT Stock Data
$223,874,191
14,667,089
29.18%
19
N/A
Biotechnology & Life Sciences
Healthcare
US
Fort Lee
